pilocarpine has been researched along with Prostatic Hyperplasia in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolf, H | 1 |
| Madsen, PO | 1 |
| Rhodes, P | 1 |
1 other study available for pilocarpine and Prostatic Hyperplasia
| Article | Year |
|---|---|
The ampicillin concentration in prostatic tissue and prostatic fluid.
Topics: Ampicillin; Animals; Biological Assay; Chronic Disease; Colon, Sigmoid; Dogs; Fistula; Humans; Male; | 1967 |